NASDAQ OMX

Weqool chooses forge by Xura to create immersive social experience in its fitness app with real time communications

3.8.2016 14:00 | NASDAQ OMX

Del

WAKEFIELD, Mass., 2016-08-03 14:00 CEST (GLOBE NEWSWIRE) -- Xura, Inc. (NASDAQ:MESG), a major innovator in Real-Time Communication (RTC) technology, today announced its forge by Xura platform has been used to provide real-time communication capabilities within new social fitness app, Weqool. forge’s RTC features enable Weqool to incorporate a combination of video and instant messaging interfaces, allowing users to meet, communicate, compete and grow friendships while exercising together virtually.

Xura partner, Blacc Spot Media, a leading WebRTC, mobile and web application development house, worked with Weqool to create a web-based prototype, utilizing forge by Xura, to meet their aim of creating a more social and immersive fitness experience, through the use of real-time communication functionality. Weqool provides an interactive, user-friendly social platform designed to enable users to watch recorded workouts created by professional fitness trainers within the app, while also facilitating positive social interactions amongst its users via video call, instant messaging and SMS.

forge by Xura was selected as the most ideal platform to use based on Blacc Spot Media’s experience, due to its scalability, ease of implementation and its range of secure, click-to-communicate capabilities, such as video calls which is a major feature of the Weqool app.

“As a developer, it is essential to have a reliable and scalable solution that can be implemented quickly and easily,” said Lantre Barr, Founder & CEO, Blacc Spot Media. “This is even more important to start ups trying to get new apps off the ground. We have worked with other clients to utilize the forge platform to transform the experience of their apps, and enjoy the versatility it can offer to enhance interactions and user engagement.”

Alex Bulley, Co-Founder of Weqool commented, “Our aim is to reinvent the concept of online fitness, by facilitating positive interactions among users with common interests through the medium of unique Weqool experiences, to make exercising more fun, engaging and social, regardless of where you are at that moment. It has been a very exciting journey to bring our proof of concept to life. The combination of Blacc Spot Media’s exceptional development expertise and forge by Xura’s RTC capabilities, have helped get our product to market quickly, allowing us to validate our concept prior to an official launch. While this is the first step with the web-based prototype, we are working to raise early stage funding to explore several new skills and activities which bring users together in a socially collaborative and mutually beneficial way.”

The Weqool prototype will be showcased for the first time during The Getting Real with RTC demo event at TMC’s Real Time Web Solutions Conference in New York, on the 3rd August. For those who can’t make it in person, you can watch a video of the Weqool app here, https://www.youtube.com/watch?v=6__EmaoqzIs.  As key sponsors of the event, the forge by Xura team will be presenting a keynote session, as well as be on hand throughout with an exhibit space to show and discuss the latest capabilities of forge by Xura, which were announced earlier this week.

By simply signing up, activating an account and joining the forge community, enterprises and developers can enhance the experience of their app or pioneer new services, while growing and managing engagement opportunities by implementing real-time, secure peer-to-peer, one-to-many and group interaction. To find out more or sign up for a forge account, visit: forge.xura.com.

About Blacc Spot Media, Inc.

Blacc Spot Media is a collaborative team of designers, developers and thought leaders specializing in Web Real-Time Communications (WebRTC). Blacc Spot Media builds custom applications, enterprise platforms and mobile applications for a wide array of clients around the world. Blacc Spot Media has strategic partnerships with many of the leading Platform as a Service (PaaS) providers in the industry. Founded in 2011, Blacc Spot Media is privately-held, with its headquarters in Atlanta, Ga. For more information, visit https://www.blaccspot.com. Contact the Blacc Spot Media team at press@blaccspot.com, or call +1.678.832.9502.

About Xura, Inc.

Xura, Inc. (NASDAQ:MESG) offers a portfolio of digital services solutions that enable global communications across a variety of mobile devices and platforms. We help communication service providers and enterprises navigate and monetize the digital ecosystem to create innovative, new experiences through our cloud-based offerings. Our solutions touch more than three billion people through 350+ service providers and enterprises in 140+ countries.  You can find us at Xura.com.

Forward-Looking Statements

This press release includes “forward-looking statements.” Forward-looking statements include statements of plans and objectives for future operations, statements of future economic performance, and statements of assumptions relating thereto. In some cases, forward-looking statements can be identified by the use of terminology such as “may,” “expects,” “plans,” “anticipates,” “estimates,” “believes,” “potential,” “projects,” “forecasts,” “intends,” or the negative thereof or other comparable terminology. By their very nature, forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results, performance and the timing of events to differ materially from those anticipated, expressed or implied by the forward-looking statements in this press release. These risks and uncertainties discussed above, as well as others, are discussed in greater detail in our filings with the SEC. The documents and reports we file with the SEC are available through us, or our website, www.Xura.com, or through the SEC's Electronic Data Gathering, Analysis, and Retrieval system (EDGAR) at www.sec.gov.

         Media Contact:
         Maria Hudson
         Xura
         maria.hudson@xura.com
         +44 7967813429
         
         Investor Relations Contact:
         Luke Todd
         Xura
         Luke.todd@Xura.com
         +1-781-213-2131

Om NASDAQ OMX

NASDAQ OMX
NASDAQ OMX
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ OMX (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra NASDAQ OMX

Registrer deg med din epostadresse under for å få de nyeste sakene fra NASDAQ OMX på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra NASDAQ OMX

Tetraphase Pharmaceuticals Announces Submission and Validation of IV Eravacycline Marketing Authorization Application by European Medicines Agency17.8.2017 14:30Pressemelding

WATERTOWN, Mass., Aug. 17, 2017 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical-stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug- resistant (MDR) infections, today announced that the Marketing Authorization Application (MAA) for IV eravacycline for the treatment of complicated intra-abdominal infections (cIAI) has been submitted and was validated by the European Medicines Agency (EMA). Eravacycline is a novel, fully-synthetic fluorocycline antibiotic being developed for the treatment of serious infections, including those caused by multidrug-resistant (MDR) pathogens. The MAA filing is based on data from the phase 3 IGNITE1 clinical trial in which eravacycline was well tolerated and demonstrated statistical non-inferiority to ertapenem using the primary endpoint of clinical response at the test-of-cure (TOC) visit. "The MAA filing represents a significant milestone for Tetraphase as it is our

RedHill Biopharma Announces U.S. Commercialization Agreement for FDA-Approved GI Product Esomeprazole Strontium Delayed-Release Capsules17.8.2017 13:00Pressemelding

RedHill was granted the exclusive rights to promote Esomeprazole Strontium Delayed-Release (DR) Capsules to gastroenterologists in certain U.S. territories Esomeprazole Strontium DR Capsules 49.3 mg is an FDA-approved, proprietary, prescription proton pump inhibitor (PPI), indicated for adults for the treatment of gastroesophageal reflux disease (GERD) and other gastrointestinal (GI) conditions   RedHill expects to initiate the U.S. promotion of Esomeprazole Strontium  DR Capsules 49.3 mg  in the coming weeks   Esomeprazole Strontium  DR Capsules 49.3 mg  will be the third commercial GI product to be promoted by RedHill in the U.S.    RedHill's GI-focused sales force currently promotes two GI s

Brand Industrial Services Announces Agreement to Acquire Venko Groep BV16.8.2017 19:40Pressemelding

Complementary core strengths provide broader range of services for customers KENNESAW, GA, Aug. 16, 2017 (GLOBE NEWSWIRE) -- Brand Industrial Services, known as BrandSafway, has signed an agreement to acquire Venko Groep BV, a portfolio company of Mentha Capital. Venko will become a part of the Brand Energy & Infrastructure Services (Brand) group. "We are very pleased to announce the agreement with Venko," said Bill Hayes, President and CEO of BrandSafway. "Our combined customers in Europe will benefit from a broader range of solutions and greater depth of expertise in access, insulation and coatings. Bringing Venko's highly specialized knowledge in coatings to BrandSafway will provide the expertise we need to expand our services in the offshore market worldwide." Based in the Netherlands, with a focus on operations in the North Sea area, Venko is a leading offshore and onshore coatings maintenance provid

Abeona Therapeutics Announces Pivotal Expansion of ABO-102 Gene Therapy Clinical Trials in Sanfilippo Syndrome Type A16.8.2017 15:38Pressemelding

NEW YORK and CLEVELAND, Aug. 16, 2017 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare diseases, today announced the pivotal expansion of its gene therapy clinical trials for patients with MPS IIIA in the USA, Europe and Australia. "We have completed the necessary regulatory and ethical committee approvals and site initiations in Europe and Australia in order to accelerate enrollment," stated Juan Ruiz, M.D., Ph.D., Abeona's Chief Medical Officer. "We remain very encouraged by the improvements observed in clinically relevant biomarkers post-dosing of ABO-102, including durable reductions in heparan sulfate measured in the CNS, reduction of organ disease pathology, and signals of CNS improvement or stabilization at one-year follow-up in Cohort 1 subjects, and look forward to providing a more fulsome clinical update at important clinical

CallidusCloud Wins Eight Gold Stevies® in the 2017 International Business Awards16.8.2017 14:00Pressemelding

CallidusCloud Lead to Money suite recognized as Best B2B New Product of the Year. LeadRocket voted Best New Product or Service of the Year in the Software - Lead Generation Solution category. DUBLIN, Calif., Aug. 16, 2017 (GLOBE NEWSWIRE) -- Callidus Software Inc. (NASDAQ:CALD), a global leader in cloud-based sales, marketing, learning, and customer experience solutions, announced today that it was named the winner of eight Gold Stevie® awards in the 2017 International Business Awards. "The eight Stevie® awards earned highlight CallidusCloud's momentum, commitment to excellence, passion for innovation and customer orientation," said Leslie Stretch, president and CEO of CallidusCloud. "They also recognize the benefits that the Lead to Money suite, honored as the Best New Product in Business-to-Business, accrues to its customers in terms of enabling faster, bigger, and more profitable sales." CallidusCloud's Go

Ascom Myco and Koutio Médipôle optimize care communications and responsiveness16.8.2017 08:00Pressemelding

Ascom Holding AG / Ascom Myco and Koutio Médipôle optimize care communications and responsiveness . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Enabled by the Ascom Myco smart device, the new Koutio Médipôle is realizing improved care delivery through seamless information flow from the point of care to anywhere. BAAR, Switzerland, Aug. 16, 2017 (GLOBE NEWSWIRE) -- The new Koutio Médipôle hospital in the New Caledonian capital Nouméa, located in the southwest Pacific Ocean, has optimized patient care communications and responsiveness for the new 645-bed facility by deploying Ascom Myco Wi-Fi devices to support clinician teams and Ascom Myco Wi-Fi/GSM handsets, used across paramedic teams. The Ascom solution is seamlessly aligned with clinical workflow and applications (nurs

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom